Handbook of Operating Procedures

I. POLICY AND GENERAL STATEMENT

德克萨斯大学健康科学中心在Houston ("university") is committed to maintaining a safe and productive environment free from substance abuse. Accordingly, the university requires all external applicants who accept an offer of employment or a post-doctoral research fellowship to submit to a drug screening.

All offers of employment to external applicants and post-doctoral research fellowships to external applicants are expressly contingent on successful completion and satisfactory results of a drug screening in accordance with this policy.

The university will designate an appropriate third-party laboratory to conduct the drug screening. Results from a laboratory other than the one designated by the university will not be accepted.

Failure or refusal to submit to the required drug test, or receiving positive results that are not cleared by the designated Medical Review Officer (“MRO”), will result in termination of the hiring process and revocation of any offer of employment or appointment. If an applicant is licensed through a professional licensing board, the university will notify the licensing entity of any positive drug screen as required by applicable law, regulation or board requirements.

The university may also screen current employees and post-doctoral research fellows when there is reasonable suspicion that they are under the influence of alcohol or drugs or are otherwise unfit for duty (see箍218，值班的健身/Fitness for Participation (Employees)andHOOP 173, Substance Abuse).

II. DEFINITIONS

Medical Review Officer (MRO): a licensed physician responsible for receiving laboratory results, who has knowledge of substance abuse disorders and has appropriate medical training to interpret and evaluate an individual’s drug screen, the individual’s medical history and other relevant biomedical information.

Drug screening/drug testing:testing for the presence of controlled substances. The drugs for which tests will be performed are marijuana metabolites, cocaine metabolites, phencyclidine (PCP), opiates, methadone, methaqualone, amphetamines, barbiturates, propoxyphene, and benzodiazepines.

Positive drug screen:高于联邦政府对受控物质的截止水平的测试结果，包括大麻代谢物，可卡因代谢物，苯基二酮（PCP），Opiates，美沙酮，甲氧酮，苯丙胺，巴比妥类药物，丙苄型，丙氧基丙烯，丙氧基苯和苯二酚和苯二氮卓类药物。

III. PROCEDURE

External applicants who accept an offer of employment or a postdoctoral research fellowship must complete the required drug screening at a university approved laboratory. After acceptance of an offer, Human Resources or designee will send the applicant written instructions for completing the drug screening. The applicant must complete the drug screening no later than the time specified after notification. Applicants who do not reside in the United States and/or do not have access to an approved laboratory must inform Human Resources immediately upon accepting an offer and receive alternate instructions. Failure to complete the drug screening within the time specified may result in termination of the hiring process and revocation of the offer of employment/appointment.

If a positive drug screen result is reported, the sample will automatically be sent by the laboratory for confirmatory testing. If the results remain positive, they will be sent to a third-party MRO for review. The MRO will determine whether the individual has a valid prescription or any other medical explanation for a positive test result. If so, the results will be deemed negative.

All final drug screening results will be sent directly from the third-party laboratory to UT Health Services. UT Health Services will maintain all drug screening results in accordance with applicable law and records retention requirements. All information from a drug screen will be confidential to the extent required by law. UT Health Services will inform Human Resources whether the applicant has cleared the screening process.

A final positive drug screen will result in termination of the hiring process and revocation of an offer of employment or appointment. .

iv。联系人

• • 人力资源
  • 713-500-3130
  • //www.tjghsg.com/hr/
• • 执行副总裁兼首席学术官办公室
  • 713-500-3062
  • //www.tjghsg.com/evpara/contact-us/leadership.htm
• • The University of Texas Health Services
  • 713-500-3267
  • https://uthealthservices.com/

---